Thrombectomy is a cost-saving procedure up to 24Â h after onset.

The treatment of ischemic stroke due to large-vessel occlusion has been revolutionized by mechanical thrombectomy (MT), as multiple trials have consistently shown improved functional outcomes compared to standard medical management both in the early and late time windows after symptom onset. However, MT is an interventional procedure that is more costly than best supportive care (BSC). We set out to study the cost-utility and budget impact of MT + BSC versus BSC alone for large-vessel occlusion using a combined decision tree and Markov model. The analysis was conducted from a Belgian payer... Mehr ...

Verfasser: Nivelle, Emilia
Dewilde, Sarah
Peeters, André
Vanhooren, Geert
Thijs, Vincent
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Schlagwörter: Brain Ischemia / Cost-Benefit Analysis / Humans / Ischemic Stroke / Quality-Adjusted Life Years / Randomized Controlled Trials as Topic / Thrombectomy / Treatment Outcome / Belgium / Cost-effectiveness / Costs / Mechanical thrombectomy / Modified Rankin scale
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26964994
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/261641